LivaNova PLC (NASDAQ:LIVN – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Thursday . The stock traded as high as $65.57 and last traded at $64.0550, with a volume of 41233 shares changing hands. The stock had previously closed at $64.06.
Analysts Set New Price Targets
A number of equities analysts have recently commented on the stock. Barclays raised their target price on shares of LivaNova from $55.00 to $58.00 and gave the stock an “equal weight” rating in a research report on Thursday, August 21st. Robert W. Baird raised their price objective on LivaNova from $63.00 to $70.00 and gave the stock an “outperform” rating in a report on Thursday, November 13th. Needham & Company LLC reaffirmed a “buy” rating and set a $64.00 target price on shares of LivaNova in a research report on Wednesday, September 3rd. Wall Street Zen downgraded LivaNova from a “strong-buy” rating to a “buy” rating in a research report on Saturday, December 6th. Finally, Mizuho raised their price target on LivaNova from $65.00 to $70.00 and gave the company an “outperform” rating in a research note on Thursday, November 13th. Five investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, LivaNova presently has an average rating of “Moderate Buy” and an average price target of $62.43.
LivaNova Price Performance
Institutional Trading of LivaNova
A number of institutional investors have recently modified their holdings of the company. Arizona State Retirement System increased its holdings in shares of LivaNova by 1.7% during the 3rd quarter. Arizona State Retirement System now owns 16,129 shares of the company’s stock worth $845,000 after buying an additional 274 shares during the last quarter. Bayforest Capital Ltd increased its stake in LivaNova by 44.8% during the third quarter. Bayforest Capital Ltd now owns 918 shares of the company’s stock worth $48,000 after acquiring an additional 284 shares during the last quarter. State of Michigan Retirement System increased its stake in LivaNova by 2.3% during the second quarter. State of Michigan Retirement System now owns 13,111 shares of the company’s stock worth $590,000 after acquiring an additional 300 shares during the last quarter. UMB Bank n.a. raised its position in LivaNova by 63.0% in the third quarter. UMB Bank n.a. now owns 792 shares of the company’s stock valued at $41,000 after purchasing an additional 306 shares during the period. Finally, GAMMA Investing LLC lifted its stake in shares of LivaNova by 182.5% in the 2nd quarter. GAMMA Investing LLC now owns 630 shares of the company’s stock valued at $28,000 after purchasing an additional 407 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors.
LivaNova Company Profile
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.
Further Reading
- Five stocks we like better than LivaNova
- Ride Out The Recession With These Dividend Kings
- Why Amazon Could Be a $300 Stock Within Weeks
- When to Sell a Stock for Profit or Loss
- Adobe Gets Post-Earnings Lift: Long-Term Outlook Favors Upside
- Stock Average Calculator
- MarketBeat Week in Review – 12/8 – 12/12
Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter.
